This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Community Health (CYH) Sells Hospital, Renews Health Net Tie-Up
by Zacks Equity Research
Community Health (CYH) announces the divestiture of its West Virginia hospital and the expansion of its alliance with Health Net, thereby undertaking initiatives to boost business prospects.
Centene (CNC) Wins Contract From DHCS to Serve Medi-Cal Members
by Zacks Equity Research
Centene's (CNC) California subsidiary receives a contract from the DHCS to better address the health requirements of the state's Medi-Cal members.
New Strong Sell Stocks for December 27th
by Zacks Equity Research
ATNI, CCS and CYH have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2022.
Acadia (ACHC) JV Opens New Behavioral Health Unit in Fort Wayne
by Zacks Equity Research
The opening of the new hospital is in line with Acadia Healthcare's (ACHC) vision to bolster its reach in the U.S. behavioral healthcare market.
Why Is Community Health Systems (CYH) Up 16.9% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Community Health (CYH) Up 27.8% Despite Q3 Earnings Miss?
by Zacks Equity Research
Community Health (CYH) expects labor inflation for 2023 to be within the 3-4% range.
Community Health Systems (CYH) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -1,140% and 1.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 5.83% and 0.76%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for September 8th
by Zacks Equity Research
CIEN, CYH and ICUI have been added to the Zacks Rank #5 (Strong Sell) List on September 8, 2022.
New Strong Sell Stocks for August 29th
by Zacks Equity Research
CCCS, CYH, and EQX have been added to the Zacks Rank #5 (Strong Sell) List on August 29, 2022.
Community Health (CYH) Down 30.3% Since Q2 Earnings Report
by Zacks Equity Research
Community Health (CYH) expects capex to remain within $400-$450 million in 2022.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Community Health Systems (CYH) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -25,100% and 6.60%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 5.77% and 0.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) Beats Q2 Earnings Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 14.71% and 0.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 108.33% and 4.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Community Health Systems (CYH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Select Medical (SEM) Stock is a Strong Buy Now
by Zacks Equity Research
Strategic alliances are bolstering Select Medical's (SEM) growth potential while mitigating the risk factor.
Do Options Traders Know Something About Community Health (CYH) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas
by Zacks Equity Research
Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.
Why Is Community Health Systems (CYH) Down 36.9% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Community Health (CYH) Boosts Obstetrics Care With Technology
by Zacks Equity Research
Community Health (CYH) employs PeriGen's technology to bring about enhanced obstetrics services and assure the safety of mothers as well as babies in the labor and delivery procedures.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
Cigna (CI) Q1 Earnings Beat on High Membership, Ups '22 EPS View
by Zacks Equity Research
Cigna's (CI) first-quarter results gain momentum from strong performances in Evernorth and Cigna Healthcare segments. A raised EPS outlook for 2022 remains noteworthy.